Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Boston Scientific pays USD 336 Million to acquire blood clot medical device firmBoston Scientific Corp. is shelling out as much as USD 336 million to take over the rest of medical device firm ...
Win-win for Biogen as its Biosimilar Gets Approval for AMD Samsung Bioepis and Biogen's biosimilar drug, Byooviz, received USFDA approval for the treatment of vision loss, Age-related mac...
FDA’s Go-Ahead to Amylyx New Drug Application for ALS Drug Amylyx Pharmaceuticals has announced its plan to submit a New Drug Application (NDA) to the U.S. FDA for its drug, AMX0035 (sodi...
ADARx bags USD 75 Million to advance its RNA tech pipelineADARx Pharmaceuticals, a biotechnology company developing RNA targeting therapeutics, announced the completion of a USD 75 million Ser...
Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 BillionA collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will co...
Pfizer’s RSV Vaccine enters in the late-stage of clinical trials As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a ...
FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone DeficiencyFor the treatment of growth failure due to deficiency of growth hormones, the USFDA appr...
Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 BillionSeattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Ro...
AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy in Patients with Amyotrophic Lateral SclerosisAstraZeneca's 39 billion USD complete a...
FDA’s Green Flag to Keytruda and Lenvima combination by Merck and Eisai for Advanced renal cell carcinoma (RCC)The FDA approved the combination of Keytruda and Lenvima produced by Merck and Ei...
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
